TY - JOUR
T1 - Global experience in cervical carotid artery stent placement
AU - Wholey, Michael H.
AU - Wholey, Mark
AU - Mathias, Klaus
AU - Roubin, Gary S.
AU - Diethrich, Edward B.
AU - Henry, Michel
AU - Bailey, Steven
AU - Bergeron, Patrice
AU - Dorros, Gerry
AU - Eles, Gustave
AU - Gaines, Peter
AU - Gomez, Camilo R.
AU - Gray, Bill
AU - Guimaraens, Juan
AU - Higashida, Randal
AU - Ho, David Sai Wah
AU - Katzen, Barry
AU - Kambara, Antonio
AU - Kumar, Vijay
AU - Laborde, Jean C.
AU - Leon, Martin
AU - Michael, Lim
AU - Londero, Hugo
AU - Mesa, Juan
AU - Musacchio, Alejandro
AU - Myla, Subbarao
AU - Ramee, Steve
AU - Rodriguez, Adolfo
AU - Rosenfield, Kenneth
AU - Sakai, Noboyuki
AU - Shawl, Fayaz
AU - Sievert, Horst
AU - Teitelbaum, George
AU - Theron, Jacque G.
AU - Vaclav, Prochazka
AU - Vozzi, Carlos
AU - Yadav, Jay S.
AU - Yoshimura, Shin Ichi
PY - 2000
Y1 - 2000
N2 - The purpose of this article is to review and update the current status of carotid artery stent placement in the world. Surveys to major interventional centers in Europe, North and South America, and Asia were initially completed in June 1997. Subsequent information from these 24 centers in addition to 12 new centers has been obtained to update the information. The survey asked the various questions regarding the patients enrolled, procedure techniques, and results of carotid stenting, including complications and restenosis. The total number of endovascular carotid stent procedures that have been performed worldwide to date included 5,210 procedures involving 4,757 patients. There was a technical success of 98.4% with 5,129 carotid arteries treated. Complications that occurred during the carotid stent placement or within a 30-day period following placement were recorded. Overall, there were 134 transient ischemic attacks (TIAs) for a rate of 2.82%. Based on the total patient population, there were 129 minor strokes with a rate of occurrence of 2.72%. The total number of major strokes was 71 for a rate of 1.49%. There were 41 deaths within a 30-day postprocedure period resulting in a mortality rate of 0.86%. The combined minor and major strokes and procedure-related death rate was 5.07%. Restenosis rates of carotid stenting have been 1.99% and 3.46% at 6 and 12 months, respectively. The rate of neurologic events after stent placement has been 1.42% at 6-12-month follow-up. Endovascular stent treatment of carotid artery atherosclerotic disease is growing as an alternative for vascular surgery, especially for patients that are high risk for standard carotid endarterectomy. The periprocedure risks for major and minor strokes and death are generally acceptable at this early stage of development and have not changed significantly since the first survey results. (C) 2000 Wiley-Liss, Inc.
AB - The purpose of this article is to review and update the current status of carotid artery stent placement in the world. Surveys to major interventional centers in Europe, North and South America, and Asia were initially completed in June 1997. Subsequent information from these 24 centers in addition to 12 new centers has been obtained to update the information. The survey asked the various questions regarding the patients enrolled, procedure techniques, and results of carotid stenting, including complications and restenosis. The total number of endovascular carotid stent procedures that have been performed worldwide to date included 5,210 procedures involving 4,757 patients. There was a technical success of 98.4% with 5,129 carotid arteries treated. Complications that occurred during the carotid stent placement or within a 30-day period following placement were recorded. Overall, there were 134 transient ischemic attacks (TIAs) for a rate of 2.82%. Based on the total patient population, there were 129 minor strokes with a rate of occurrence of 2.72%. The total number of major strokes was 71 for a rate of 1.49%. There were 41 deaths within a 30-day postprocedure period resulting in a mortality rate of 0.86%. The combined minor and major strokes and procedure-related death rate was 5.07%. Restenosis rates of carotid stenting have been 1.99% and 3.46% at 6 and 12 months, respectively. The rate of neurologic events after stent placement has been 1.42% at 6-12-month follow-up. Endovascular stent treatment of carotid artery atherosclerotic disease is growing as an alternative for vascular surgery, especially for patients that are high risk for standard carotid endarterectomy. The periprocedure risks for major and minor strokes and death are generally acceptable at this early stage of development and have not changed significantly since the first survey results. (C) 2000 Wiley-Liss, Inc.
KW - Balloon dilatation
KW - Carotid occlusive disease
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=18344406356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18344406356&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1522-726X(200006)50:2<160::AID-CCD2>3.0.CO;2-E
DO - 10.1002/(SICI)1522-726X(200006)50:2<160::AID-CCD2>3.0.CO;2-E
M3 - Article
C2 - 10842380
AN - SCOPUS:18344406356
SN - 1522-1946
VL - 50
SP - 160
EP - 167
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
IS - 2
ER -